Applied BioCode Valuation
| 6598 Stock | TWD 23.60 0.45 1.87% |
At this time, the firm appears to be overvalued. Applied BioCode shows a prevailing Real Value of NT$20.09 per share. The current price of the firm is NT$23.6. Our model approximates the value of Applied BioCode from analyzing the firm fundamentals such as Return On Equity of -0.19, profit margin of (0.46) %, and Current Valuation of 1.72 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Applied BioCode's price fluctuation is very steady at this time. Calculation of the real value of Applied BioCode is based on 3 months time horizon. Increasing Applied BioCode's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Applied stock is determined by what a typical buyer is willing to pay for full or partial control of Applied BioCode. Since Applied BioCode is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Applied Stock. However, Applied BioCode's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.6 | Real 20.09 | Hype 23.6 | Naive 23.32 |
The intrinsic value of Applied BioCode's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Applied BioCode's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Applied BioCode helps investors to forecast how Applied stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Applied BioCode more accurately as focusing exclusively on Applied BioCode's fundamentals will not take into account other important factors: About Applied BioCode Valuation
Our relative valuation model uses a comparative analysis of Applied BioCode. We calculate exposure to Applied BioCode's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Applied BioCode's related companies.Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company was founded in 2016 and is based in Santa Fe Springs, California. APPLIED BIOCODE operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Applied BioCode's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Applied BioCode's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Applied BioCode's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Applied BioCode's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Applied BioCode's revenue streams: Identify Applied BioCode's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Applied BioCode's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Applied BioCode's growth potential: Evaluate Applied BioCode's management, business model, and growth potential.
- Determine Applied BioCode's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Applied BioCode's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Applied Stock Analysis
When running Applied BioCode's price analysis, check to measure Applied BioCode's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied BioCode is operating at the current time. Most of Applied BioCode's value examination focuses on studying past and present price action to predict the probability of Applied BioCode's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied BioCode's price. Additionally, you may evaluate how the addition of Applied BioCode to your portfolios can decrease your overall portfolio volatility.